IP Library Granted Patent US 9,360,457
Granted Patent B2
US 9,360,457 · App. 13/402,566 · Granted Jun 7, 2016

NMR systems and methods for the rapid detection of analytes

Inventors: Lori Anne Neely (Reading, MA); Mark John Audeh (Brighton, MA); Rahul K. Dhanda (Somerville, MA); Marilyn Lee Fritzemeier (Lexington, MA); Daniella Lynn Plourde (Arlington, MA); Charles William Rittershaus (Malden, MA)
Assignee: T2 Biosystems, Inc.
G01N27/745C12Q1/6816C12Q1/6895G01N24/08G01R33/302G01R33/465C12Q2537/125C12Q2563/143C12Q2563/155C12Q2565/113C12Q2565/633C12Q2600/156G01R33/448Y10T436/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,360,457
App. No.
13/402,566
Granted
Jun 7, 2016
Kind
B2
Abstract

This invention features systems and methods for the detection of analytes, and their use in the treatment and diagnosis of disease.

Claims (12)

1. A method for amplifying a target fungal nucleic acid in a whole blood sample, the method comprising:

(a) contacting a whole blood sample suspected of containing one or more fungal cells with an erythrocyte lysis agent, thereby lysing red blood cells;

(b) centrifuging the product of step (a) to form a supernatant and a pellet;

(c) discarding some or all of the supernatant of step (b) and resuspending the pellet to form an extract;

(d) combining said extract of step (c) with beads to form a mixture and agitating the mixture to form a lysate, said lysate containing both subject cell nucleic acid and fungal nucleic acid; and

(e) providing the lysate of step (d) in a detection tube and amplifying fungal nucleic acids therein by PCR to form an amplified lysate solution;

wherein ten fungal cells per milliliter of said whole blood sample is sufficient to permit amplification of said target fungal nucleic acid.

2. The method of claim 1 , wherein the amplifying of step (e) comprises amplifying a Candida nucleic acid to be detected in the presence of a forward primer and a reverse primer, each of which is universal to multiple Candida species to form a solution comprising a Candida amplicon.

3. The method of claim 1 , wherein the lysing step (a) is by detergent lysis or hypotonic lysis.

4. The method of claim 1 , wherein said amplifying step (e) comprises asymmetric polymerase chain reaction.

5. The method of claim 1 , wherein said amplified lysate solution of step (e) comprises whole blood proteins and non-target oligonucleotides.

6. The method of claim 1 , further comprising (f) detecting said amplified target nucleic acid.

Assignments (2)
SECURITY INTEREST Recorded Dec 30, 2016
From: T2 BIOSYSTEMS, INC.
To: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 041226/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2012
From: NEELY, LORI ANNE; AUDEH, MARK JOHN; DHANDA, RAHUL; FRITZEMEIER, MARILYN LEE; PLOURDE, DANIELLA LYNN; RITTERSHAUS, CHARLES WILLIAM
To: T2 BIOSYSTEMS, INC.
Reel/Frame 027819/0755 →
Continuity (7)
Continuation 13363916 · Feb 1, 2012
Continuation 13384051
Continuation In Part 12910594 · Oct 22, 2010
Provisional Application 61414141 · Nov 16, 2010
Provisional Application 61418465 · Dec 1, 2010
Provisional Application 61497374 · Jun 15, 2011
Related Publication 20120301888A1 · Nov 29, 2012